Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-09-21

FDA Approved: HYDROCODONE BITARTRATE AND ACETAMINOPHEN — Supplemental Application (Genus Lifesciences Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Genus Lifesciences' hydrocodone bitartrate and acetaminophen product, authorizing its continued marketing under …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HYDROCODONE BITARTRATE AND ACETAMINOPHEN (Hydrocodone bitartrate and acetaminophen)

Snippet

SUPPL AP for HYDROCODONE BITARTRATE AND ACETAMINOPHEN (HYDROCODONE BITARTRATE AND ACETAMINOPHEN)